Correlation Between Anebulo Pharmaceuticals and INmune Bio

Can any of the company-specific risk be diversified away by investing in both Anebulo Pharmaceuticals and INmune Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anebulo Pharmaceuticals and INmune Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Anebulo Pharmaceuticals and INmune Bio, you can compare the effects of market volatilities on Anebulo Pharmaceuticals and INmune Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anebulo Pharmaceuticals with a short position of INmune Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anebulo Pharmaceuticals and INmune Bio.

Diversification Opportunities for Anebulo Pharmaceuticals and INmune Bio

-0.05

Correlation Coefficient

Anebulo Pharmaceuticals  INmune Bio

Good diversification

The 3 months correlation between Anebulo and INmune is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding Anebulo Pharmaceuticals and INmune Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on INmune Bio and Anebulo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anebulo Pharmaceuticals are associated (or correlated) with INmune Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of INmune Bio has no effect on the direction of Anebulo Pharmaceuticals i.e., Anebulo Pharmaceuticals and INmune Bio go up and down completely randomly.

Pair Corralation between Anebulo Pharmaceuticals and INmune Bio

Given the investment horizon of 90 days Anebulo Pharmaceuticals is expected to under-perform the INmune Bio. In addition to that, Anebulo Pharmaceuticals is 1.04 times more volatile than INmune Bio. It trades about 0.0 of its total potential returns per unit of risk. INmune Bio is currently generating about 0.15 per unit of volatility. If you would invest  465.00  in INmune Bio on December 29, 2024 and sell it today you would earn a total of  287.00  from holding INmune Bio or generate 61.72% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Anebulo Pharmaceuticals  vs.  INmune Bio

Anebulo Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Anebulo Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong technical and fundamental indicators, Anebulo Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

INmune Bio

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in INmune Bio are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak primary indicators, INmune Bio sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Anebulo Pharmaceuticals and INmune Bio

The main advantage of trading using opposite Anebulo Pharmaceuticals and INmune Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anebulo Pharmaceuticals position performs unexpectedly, INmune Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in INmune Bio will offset losses from the drop in INmune Bio's long position.

The idea behind Anebulo Pharmaceuticals and INmune Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.